Hariprasad Vankayalapati

Company: Biolexis Therapeutics

Job title: Chief Scientific Officer

Seminars:

Design and Development of QMD Driven Physiological Biomolecular GPCR Small Molecule Agonist Complexes 11:15 am

Peptides physiological confirmation, binding mode, design of peptidomimetics & to constraining peptidomimetics into peptides utilizing unnatural amino acids, we can develop orally agents. Further profiling against several GPCRs as targets for selective and stable peptides treating metabolic diseases Generate natural peptide sequence stable conformer, search for amidic back-bone, alpha C, acid and amine mimetic functional…Read more

day: Conference Day Two

Roundtable Discussion: Examining the Future Possibilities of Modalities for GPCR-Targeted Drugs to Become More Effective & Feasible 3:30 pm

Can we develop orally available peptides? How do you make a peptidic starting point into a small molecule? What are the different modalities that can be employed to target different GPCRs?Read more

day: Conference Day One